Trump eyes escalating tariffs on generics to push U.S. production onshore

1 min read
Source: CNBC
Trump eyes escalating tariffs on generics to push U.S. production onshore
Photo: CNBC
TL;DR

Trump outlined a phased tariff plan on imported generic drugs: zero tariffs for two years starting Aug 1, 2026, then a 100% levy in Aug 2028 and 200% a year later, while tariffs on patented drugs stay the same. The move aims to force generic manufacturers to relocate production to the U.S. as part of a broader push to lower drug prices and reshape supply chains, amid ongoing dynamics with India and China in pharma.

Share this article

Want the full story? Read the original reporting

Read on CNBC